RxDoctor Payments Data

Johanna Kimberl

Physician Assistant · Alpharetta, GANPI 1477915718

Payments from drug & device makers

$1,668in general payments, 2019–2025

Across 105 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$413
  • Amgen$203
  • Mylan Specialty L.p.$174
  • Astellas Pharma US Inc$163
  • Novo Nordisk$106
  • Boehringer Ingelheim$77
  • plus $531 from 17 others

What the payments were for

  • Food & beverage$1,56094%
  • Education$1086%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,668 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$20,938
MyrbetriqMirabegron12$6,252
Potassium Chloride24$263
Losartan Potassium29$246
Atorvastatin Calcium27$197
Levothyroxine Sodium21$195
Gabapentin15$188
Omeprazole12$155
Montelukast Sodium11$136
Estradiol12$123
Simvastatin11$92
Lisinopril13$63
Rosuvastatin Calcium13$46
Methylprednisolone13$41
Hydrochlorothiazide13$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$106$20,93816 claims
Astellas Pharma US IncMyrbetriq$163$6,25212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Alpharetta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →